Related Experiment Video
Updated: Jun 18, 2025

07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.1K
KGRLFF: Detecting Drug-Drug Interactions Based on Knowledge Graph Representation Learning and Feature Fusion
Summary
This study introduces a hybrid method, Knowledge Graph Representation Learning and Feature Fusion (KGRLFF), for predicting drug-drug interactions (DDIs). KGRLFF effectively integrates biomedical knowledge graphs and drug molecular structures to improve DDI prediction accuracy.
Area of Science:
- Pharmacology
- Bioinformatics
- Computational Chemistry
Background:
- Accurate drug-drug interaction (DDI) prediction is crucial for drug development and patient safety.
- Existing DDI prediction models often rely on single data sources and struggle with biomedical knowledge graphs.
Purpose of the Study:
- To propose a novel hybrid method, KGRLFF, for enhanced DDI prediction.
- To leverage both biomedical knowledge graphs and drug molecular structures for improved prediction.
Main Methods:
- Utilized Bidirectional Random Walk sampling (BRWP) for higher-order neighborhood information from knowledge graphs.
- Employed Knowledge Graph-based Cyclic Recursive Aggregation (KGCRA) for learning drug embeddings.
- Integrated drug molecular structures for structured feature learning.
- Developed a Feature Representation Fusion Strategy (FRFS) to combine embeddings and structured features.
Main Results:
- The KGRLFF method demonstrated feasibility in predicting potential drug-drug interactions.
- The hybrid approach effectively exploits information from both knowledge graphs and molecular structures.
Conclusions:
- KGRLFF offers a promising approach for accurate DDI prediction.
- Integrating diverse data sources enhances the performance of DDI prediction models.
Related Concept Videos
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Agonism and Antagonism: Quantification
336
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
336
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Drug-Receptor Interaction: Antagonist
2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K

